Target intelligence / Profile preview

RNA, 7SL, cytoplasmic 789, pseudogene (RN7SL789P)

Target
RN7SL789P
Molecular classification
Other (Pseudogene, processed RNA pseudogene)
01

Overview

RNA, 7SL, cytoplasmic 789, pseudogene (RN7SL789P) is a processed pseudogene related to the 7SL RNA, a non-coding RNA that is the RNA component of the signal recognition particle (SRP)[1][3][6]. Functional 7SL RNA is essential for targeting secretory proteins to the endoplasmic reticulum by pausing their translation and facilitating membrane translocation[4][5]. However, pseudogenes such as RN7SL789P are nonfunctional sequences derived from 7SL that do not encode a functional RNA product, do not participate in protein targeting, and are not known to have a regulatory or enzymatic role[2][3][6].\nMost human 7SL-related genomic sequences are pseudogenes, resulting from retrotranspositional events and gene duplication, and typically display truncated or mutated sequences preventing their function[3][6]. There is no evidence that RN7SL789P is a therapeutic target, nor is it implicated in any known disease processes, drug interactions, or safety concerns.\nThis is not a canonical molecular target but merely a relic of genomic evolution and is generally annotated for completeness in genomic analyses[2][3][6].\n\nKey points:\n- RN7SL789P is a pseudogene: it does not code for a functional RNA or protein and has no known physiological or pathological function[1][2][3][6].\n- Not a drug target: It is not considered a therapeutic target, receptor, enzyme, transporter, or regulatory RNA in any context[1].\n- No biomarker or disease association: There are no clinical, diagnostic, or therapeutic roles described[1][3][6].\n- Is_incorrect = true: Listing this as a drug/therapeutic target is incorrect; it is a non-functional genomic sequence (pseudogene)[1][2][3][6].

Other names
RN7SL789P
02

Biological functions

Other (no known active biological function; see description)
03

Disease associations

Other (no known disease association)

Beyond the preview

Go deeper on RNA, 7SL, cytoplasmic 789, pseudogene (RN7SL789P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, 7SL, cytoplasmic 789, pseudogene (RN7SL789P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call